Latest news
Sanofi 2026 Q2 - Results - Earnings Call Presentation (NEOE:SAN:CA) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 23:02:59 GMTNovavax raises 2026 revenue outlook after Q2 beat - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 12:51:00 GMTSanofi rated Buy with 33.5% upside, driven by D... - PluangPluang · Thu, 06 Aug 2026 10:57:05 GMTSanofi Stock: How I Leveraged This Undervalued Dividend Aristocrat (NASDAQ:SNY) - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 10:13:03 GMTSanofi beats Q2 growth expectations on Dupixent sales surge (SNY:NASDAQ) - Seeking AlphaSeeking Alpha · Thu, 30 Jul 2026 07:00:00 GMTRegeneron stock rises after strong Q2 2026 beat (REGN:NASDAQ) - Seeking AlphaSeeking Alpha · Thu, 30 Jul 2026 07:00:00 GMTNovavax: The Beaten-Down COVID-19 Darling (NASDAQ:NVAX) - Seeking AlphaSeeking Alpha · Tue, 28 Jul 2026 07:00:00 GMTNektar: Sanofi’s Exit Clears A Competitor But Raises The Bar In Atopic Dermatitis (NKTR) - Seeking AlphaSeeking Alpha · Mon, 27 Jul 2026 07:00:00 GMT